SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Optmaster who wrote (2617)7/7/1999 2:50:00 PM
From: Joe  Read Replies (1) of 4140
 
The FDA has already been reviewing SNRS clinical data. The data will be discussed at the Ophthalmic Devices Panel of the FDA on the 22nd. ODP will recommend that the FDA approve LTK. From that point it can take anywhere from 2 to 6 months for actual FDA approval. Most knowledgeable people think the period will be 2 to 3 months.

I would like to see they get approval prior to the end of Q3 so we will see some preliminary sales figures. Also that means we would see procedure numbers for a full quarter, Q4. The future picture for the stock will be well evolved when the year is reported in February of 2000.

Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext